Showing 3 of 3 recruiting trials for “Anaplastic large cell lymphoma”
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
👨⚕️ Suresh Mahabhashyam, MD, MPH, Corvus Pharmaceuticals, Inc.📍 27 sites📅 Started Oct 2024View details ↗
A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma
RecruitingNCT04220970 ↗
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →